But in recent times, a handful of dogged psychiatrists have revived the field. A Johns Hopkins 2006 double-blind review (meaning neither trial contributors nor researchers understood if a subject matter was receiving psilocybin or placebo), revealed in the journal Psychopharmacology, shown that psilocybin could give healthy volunteers “ordeals ge